-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical News, April 27.
Recently, clinician Zhang Yu published a long article on the Internet exposing the "shadow treatment of tumor", which caused a shock of public opinion.
On April 19, the National Health Commission responded on its official information platform that after it was concerned about the online information of "The third hospital of Beijing Medical College's oncologists reported the shady tumor treatment", it attached great importance to it and immediately organized the relevant situation and reported problems.
Investigate and verify.
Recently, clinician Zhang Yu published a long article on the Internet exposing the "shadow treatment of tumor", which caused a shock of public opinion.
On April 19, the National Health Commission responded on its official information platform that after it was concerned about the online information of "The third hospital of Beijing Medical College's oncologists reported the shady tumor treatment", it attached great importance to it and immediately organized the relevant situation and reported problems.
Investigate and verify.
Zhang Yu pointed out in a long article that a considerable proportion of cancer patients have spent unnecessary and expensive expenses, and a certain proportion of patients died due to irregular or even incorrect diagnosis and treatment.
Zhang Yu cited a tumor patient who had both financial and financial resources.
After receiving treatment by Lu Wei, deputy chief physician of Xinhua Hospital affiliated to Shanghai Jiaotong University, this patient died unfortunately and owed more than 100,000 yuan in debt.
Zhang Yu cited a tumor patient who had both financial and financial resources.
After receiving treatment by Lu Wei, deputy chief physician of Xinhua Hospital affiliated to Shanghai Jiaotong University, this patient died unfortunately and owed more than 100,000 yuan in debt.
Zhang Yu said that this patient "expensively increased by 10 times and died earlier" because of Lu Wei's treatment plan, which included abandoning the lower cost treatment plan and switching to the "extraordinary second-line treatment plan with sharply rising costs" and Ineffective, expensive, and illegal NK treatment.
Zhang Yu said that such a diagnosis and treatment plan is a typical over-medical behavior.
Zhang Yu said that such a diagnosis and treatment plan is a typical over-medical behavior.
China Youth Daily and China Youth Daily interviewed Zheng Xueqian, the executive vice chairman and secretary-general of the Medical Legal Professional Committee of the Chinese Hospital Association, an expert in petitions, medical administration, medical management, and legal consultation from the National Health Commission, and the director of Beijing Huawei Law Firm.
As an expert in the field of medical and health law, Zheng Xueqian has more than 30 years of experience in handling medical disputes.
She said that the Basic Medical and Health Promotion Law that came into effect in June 2020 clearly states that medical personnel should follow the laws of medical science and comply with relevant clinical practices.
Diagnosis and treatment technical specifications, various operating specifications, and medical ethics specifications, use appropriate technologies and drugs, make reasonable diagnosis and treatment, and treat patients due to diseases.
Excessive medical treatment shall not be performed on patients.
This is the first time that the country has written "excessive medical treatment" into the law.
The previous tort liability law used the term "excessive inspection".
She said that the Basic Medical and Health Promotion Law that came into effect in June 2020 clearly states that medical personnel should follow the laws of medical science and comply with relevant clinical practices.
Diagnosis and treatment technical specifications, various operating specifications, and medical ethics specifications, use appropriate technologies and drugs, make reasonable diagnosis and treatment, and treat patients due to diseases.
Excessive medical treatment shall not be performed on patients.
This is the first time that the country has written "excessive medical treatment" into the law.
The previous tort liability law used the term "excessive inspection".
Zheng Xueqian said: “Because excessive medical treatment is difficult to define.
Although many diseases in our country have standardized diagnosis and treatment guidelines, everyone’s situation is different.
When a patient has a special condition, the doctor cannot ignore it, so there may be some Adjust the plan.
" These tentative explorations that go beyond the diagnosis and treatment guidelines have become a fuzzy zone of whether it is over-medical.
Although many diseases in our country have standardized diagnosis and treatment guidelines, everyone’s situation is different.
When a patient has a special condition, the doctor cannot ignore it, so there may be some Adjust the plan.
" These tentative explorations that go beyond the diagnosis and treatment guidelines have become a fuzzy zone of whether it is over-medical.
Zheng Xueqian believes that the important value of Zhang Yu's article exposing the "shadow of tumor treatment" is to make the country pay attention to this matter and standardize tumor treatment, while also reminding doctors of self-discipline.
In its response, the National Health Commission pointed out that once relevant issues are verified, they will be dealt with strictly according to laws and regulations, and will never be tolerated, and will continue to promote cancer diagnosis and treatment management, further improve the management system and standard system, strengthen supervision and guidance, and ensure relevant requirements Put it in place, focus on improving the standardization of tumor diagnosis and treatment, and safeguard the people's health rights.
In its response, the National Health Commission pointed out that once relevant issues are verified, they will be dealt with strictly according to laws and regulations, and will never be tolerated, and will continue to promote cancer diagnosis and treatment management, further improve the management system and standard system, strengthen supervision and guidance, and ensure relevant requirements Put it in place, focus on improving the standardization of tumor diagnosis and treatment, and safeguard the people's health rights.
In an interview, Zheng Xueqian emphasized that although Dr.
Zhang Yu’s article has attracted a lot of attention, “but it does not mean that all tumor treatments are not standardized.
Over-medical treatment is only a rare phenomenon, and most doctors do not.
” Long-term handling of medical disputes.
Zheng Xueqian of China is worried that the slightly eased doctor-patient relationship in China's fight against the new crown pneumonia epidemic may be damaged by this incident.
Zhang Yu’s article has attracted a lot of attention, “but it does not mean that all tumor treatments are not standardized.
Over-medical treatment is only a rare phenomenon, and most doctors do not.
” Long-term handling of medical disputes.
Zheng Xueqian of China is worried that the slightly eased doctor-patient relationship in China's fight against the new crown pneumonia epidemic may be damaged by this incident.
Zheng Xueqian said that excessive medical treatment is more of an ethical issue.
She told reporters that she had participated in a medical ethics committee meeting of a hospital.
It is also a patient with advanced cancer.
The domestic known treatment options have been used, but they are still ineffective.
The patient learned that a foreign pharmaceutical company was conducting a clinical trial of a new drug.
It was said that the effect was good, but the drug was not yet on the market.
The patient wants to buy this unlisted drug for treatment, but the pharmaceutical company needs him to prescribe it in China.
She told reporters that she had participated in a medical ethics committee meeting of a hospital.
It is also a patient with advanced cancer.
The domestic known treatment options have been used, but they are still ineffective.
The patient learned that a foreign pharmaceutical company was conducting a clinical trial of a new drug.
It was said that the effect was good, but the drug was not yet on the market.
The patient wants to buy this unlisted drug for treatment, but the pharmaceutical company needs him to prescribe it in China.
This case not only provides a solution to avoid excessive medical treatment.
At the same time, it also illustrates the complexity and uncertainty of tumor treatment, especially in the treatment of advanced malignant tumors, the problem will be more prominent.
How to strike a balance between exploratory treatment and normative guidelines? Zheng Xueqian believes that the supervision of policies pharmnet.
com.
cn/" target="_blank">and regulations , including the National Health Commission and the National Medical Insurance Bureau, must be necessary; in addition, hospitals should also do related self-examination work, which includes ethical review of the new technology diagnosis and treatment process, which is complicated Tumor medication plans should carry out multidisciplinary consultations or review by superior doctors in the department; finally, doctors should do a good job of personal self-discipline, not only to practice according to law, but also to consider the patient's experience in the diagnosis and treatment process.
At the same time, it also illustrates the complexity and uncertainty of tumor treatment, especially in the treatment of advanced malignant tumors, the problem will be more prominent.
How to strike a balance between exploratory treatment and normative guidelines? Zheng Xueqian believes that the supervision of policies pharmnet.
com.
cn/" target="_blank">and regulations , including the National Health Commission and the National Medical Insurance Bureau, must be necessary; in addition, hospitals should also do related self-examination work, which includes ethical review of the new technology diagnosis and treatment process, which is complicated Tumor medication plans should carry out multidisciplinary consultations or review by superior doctors in the department; finally, doctors should do a good job of personal self-discipline, not only to practice according to law, but also to consider the patient's experience in the diagnosis and treatment process.
The implementation of the above-mentioned various supervisory measures must ultimately be based on the fact that doctors should objectively clarify the pros and cons for patients, and seek patient consent, rather than actively induce them.
One of the core controversies of the "tumor treatment shady" revealed by Dr.
Zhang Yu this time is whether the NK therapy worth tens of thousands of dollars was requested by the patient or induced by the doctor.
According to related reports, the daughter of the deceased patient insisted that this treatment plan was recommended by Lu Wei, while Lu Wei said in an interview with the media that it was not his introduction, but that the family members learned about it from other channels and came to consult.
Lu Wei said After finishing the principle, the family decided to use NK therapy.
Zhang Yu this time is whether the NK therapy worth tens of thousands of dollars was requested by the patient or induced by the doctor.
According to related reports, the daughter of the deceased patient insisted that this treatment plan was recommended by Lu Wei, while Lu Wei said in an interview with the media that it was not his introduction, but that the family members learned about it from other channels and came to consult.
Lu Wei said After finishing the principle, the family decided to use NK therapy.
At present, there is no official conclusion on the right and wrong of both doctors and patients.
On April 19, after the National Health Commission issued an investigation announcement on its official Weibo account @, it caused heated discussions among netizens.
After many days of public opinion fermentation, the reporter found that the most liked message on this Weibo was: "Check it out! Neither the doctor's heart nor the patient's heart can be chilled!"
On April 19, after the National Health Commission issued an investigation announcement on its official Weibo account @, it caused heated discussions among netizens.
After many days of public opinion fermentation, the reporter found that the most liked message on this Weibo was: "Check it out! Neither the doctor's heart nor the patient's heart can be chilled!"
Medical News, April 27.
Recently, clinician Zhang Yu published a long article on the Internet exposing the "shadow treatment of tumor", which caused a shock of public opinion.
On April 19, the National Health Commission responded on its official information platform that after it was concerned about the online information of "The third hospital of Beijing Medical College's oncologists reported the shady tumor treatment", it attached great importance to it and immediately organized the relevant situation and reported problems.
Investigate and verify.
Recently, clinician Zhang Yu published a long article on the Internet exposing the "shadow treatment of tumor", which caused a shock of public opinion.
On April 19, the National Health Commission responded on its official information platform that after it was concerned about the online information of "The third hospital of Beijing Medical College's oncologists reported the shady tumor treatment", it attached great importance to it and immediately organized the relevant situation and reported problems.
Investigate and verify.
Zhang Yu pointed out in a long article that a considerable proportion of cancer patients have spent unnecessary and expensive expenses, and a certain proportion of patients died due to irregular or even incorrect diagnosis and treatment.
Zhang Yu cited a tumor patient who had both financial and financial resources.
After receiving treatment by Lu Wei, deputy chief physician of Xinhua Hospital affiliated to Shanghai Jiaotong University, this patient died unfortunately and owed more than 100,000 yuan in debt.
Zhang Yu cited a tumor patient who had both financial and financial resources.
After receiving treatment by Lu Wei, deputy chief physician of Xinhua Hospital affiliated to Shanghai Jiaotong University, this patient died unfortunately and owed more than 100,000 yuan in debt.
Zhang Yu said that this patient "expensively increased by 10 times and died earlier" because of Lu Wei's treatment plan, which included abandoning the lower cost treatment plan and switching to the "extraordinary second-line treatment plan with sharply rising costs" and Ineffective, expensive, and illegal NK treatment.
Zhang Yu said that such a diagnosis and treatment plan is a typical over-medical behavior.
Zhang Yu said that such a diagnosis and treatment plan is a typical over-medical behavior.
China Youth Daily and China Youth Daily interviewed Zheng Xueqian, the executive vice chairman and secretary-general of the Medical Legal Professional Committee of the Chinese Hospital Association, an expert in petitions, medical administration, medical management, and legal consultation from the National Health Commission, and the director of Beijing Huawei Law Firm.
As an expert in the field of medical and health law, Zheng Xueqian has more than 30 years of experience in handling medical disputes.
She said that the Basic Medical and Health Promotion Law that came into effect in June 2020 clearly states that medical personnel should follow the laws of medical science and comply with relevant clinical practices.
Diagnosis and treatment technical specifications, various operating specifications, and medical ethics specifications, use appropriate technologies and drugs, make reasonable diagnosis and treatment, and treat patients due to diseases.
Excessive medical treatment shall not be performed on patients.
This is the first time that the country has written "excessive medical treatment" into the law.
The previous tort liability law used the term "excessive inspection".
She said that the Basic Medical and Health Promotion Law that came into effect in June 2020 clearly states that medical personnel should follow the laws of medical science and comply with relevant clinical practices.
Diagnosis and treatment technical specifications, various operating specifications, and medical ethics specifications, use appropriate technologies and drugs, make reasonable diagnosis and treatment, and treat patients due to diseases.
Excessive medical treatment shall not be performed on patients.
This is the first time that the country has written "excessive medical treatment" into the law.
The previous tort liability law used the term "excessive inspection".
Zheng Xueqian said: “Because excessive medical treatment is difficult to define.
Although many diseases in our country have standardized diagnosis and treatment guidelines, everyone’s situation is different.
When a patient has a special condition, the doctor cannot ignore it, so there may be some Adjust the plan.
" These tentative explorations that go beyond the diagnosis and treatment guidelines have become a fuzzy zone of whether it is over-medical.
Although many diseases in our country have standardized diagnosis and treatment guidelines, everyone’s situation is different.
When a patient has a special condition, the doctor cannot ignore it, so there may be some Adjust the plan.
" These tentative explorations that go beyond the diagnosis and treatment guidelines have become a fuzzy zone of whether it is over-medical.
Zheng Xueqian believes that the important value of Zhang Yu's article exposing the "shadow of tumor treatment" is to make the country pay attention to this matter and standardize tumor treatment, while also reminding doctors of self-discipline.
In its response, the National Health Commission pointed out that once relevant issues are verified, they will be dealt with strictly according to laws and regulations, and will never be tolerated, and will continue to promote cancer diagnosis and treatment management, further improve the management system and standard system, strengthen supervision and guidance, and ensure relevant requirements Put it in place, focus on improving the standardization of tumor diagnosis and treatment, and safeguard the people's health rights.
In its response, the National Health Commission pointed out that once relevant issues are verified, they will be dealt with strictly according to laws and regulations, and will never be tolerated, and will continue to promote cancer diagnosis and treatment management, further improve the management system and standard system, strengthen supervision and guidance, and ensure relevant requirements Put it in place, focus on improving the standardization of tumor diagnosis and treatment, and safeguard the people's health rights.
In an interview, Zheng Xueqian emphasized that although Dr.
Zhang Yu’s article has attracted a lot of attention, “but it does not mean that all tumor treatments are not standardized.
Over-medical treatment is only a rare phenomenon, and most doctors do not.
” Long-term handling of medical disputes.
Zheng Xueqian of China is worried that the slightly eased doctor-patient relationship in China's fight against the new crown pneumonia epidemic may be damaged by this incident.
Zhang Yu’s article has attracted a lot of attention, “but it does not mean that all tumor treatments are not standardized.
Over-medical treatment is only a rare phenomenon, and most doctors do not.
” Long-term handling of medical disputes.
Zheng Xueqian of China is worried that the slightly eased doctor-patient relationship in China's fight against the new crown pneumonia epidemic may be damaged by this incident.
Zheng Xueqian said that excessive medical treatment is more of an ethical issue.
She told reporters that she had participated in a medical ethics committee meeting of a hospital.
It is also a patient with advanced cancer.
The domestic known treatment options have been used, but they are still ineffective.
The patient learned that a foreign pharmaceutical company was conducting a clinical trial of a new drug.
It was said that the effect was good, but the drug was not yet on the market.
The patient wants to buy this unlisted drug for treatment, but the pharmaceutical company needs him to prescribe it in China.
She told reporters that she had participated in a medical ethics committee meeting of a hospital.
It is also a patient with advanced cancer.
The domestic known treatment options have been used, but they are still ineffective.
The patient learned that a foreign pharmaceutical company was conducting a clinical trial of a new drug.
It was said that the effect was good, but the drug was not yet on the market.
The patient wants to buy this unlisted drug for treatment, but the pharmaceutical company needs him to prescribe it in China.
This case not only provides a solution to avoid excessive medical treatment.
At the same time, it also illustrates the complexity and uncertainty of tumor treatment, especially in the treatment of advanced malignant tumors, the problem will be more prominent.
How to strike a balance between exploratory treatment and normative guidelines? Zheng Xueqian believes that the supervision of policies pharmnet.
com.
cn/" target="_blank">and regulations , including the National Health Commission and the National Medical Insurance Bureau, must be necessary; in addition, hospitals should also do related self-examination work, which includes ethical review of the new technology diagnosis and treatment process, which is complicated Tumor medication plans should carry out multidisciplinary consultations or review by superior doctors in the department; finally, doctors should do a good job of personal self-discipline, not only to practice according to law, but also to consider the patient's experience in the diagnosis and treatment process.
At the same time, it also illustrates the complexity and uncertainty of tumor treatment, especially in the treatment of advanced malignant tumors, the problem will be more prominent.
How to strike a balance between exploratory treatment and normative guidelines? Zheng Xueqian believes that the supervision of policies pharmnet.
com.
cn/" target="_blank">and regulations , including the National Health Commission and the National Medical Insurance Bureau, must be necessary; in addition, hospitals should also do related self-examination work, which includes ethical review of the new technology diagnosis and treatment process, which is complicated Tumor medication plans should carry out multidisciplinary consultations or review by superior doctors in the department; finally, doctors should do a good job of personal self-discipline, not only to practice according to law, but also to consider the patient's experience in the diagnosis and treatment process.
The implementation of the above-mentioned various supervisory measures must ultimately be based on the fact that doctors should objectively clarify the pros and cons for patients, and seek patient consent, rather than actively induce them.
One of the core controversies of the "tumor treatment shady" revealed by Dr.
Zhang Yu this time is whether the NK therapy worth tens of thousands of dollars was requested by the patient or induced by the doctor.
According to related reports, the daughter of the deceased patient insisted that this treatment plan was recommended by Lu Wei, while Lu Wei said in an interview with the media that it was not his introduction, but that the family members learned about it from other channels and came to consult.
Lu Wei said After finishing the principle, the family decided to use NK therapy.
Zhang Yu this time is whether the NK therapy worth tens of thousands of dollars was requested by the patient or induced by the doctor.
According to related reports, the daughter of the deceased patient insisted that this treatment plan was recommended by Lu Wei, while Lu Wei said in an interview with the media that it was not his introduction, but that the family members learned about it from other channels and came to consult.
Lu Wei said After finishing the principle, the family decided to use NK therapy.
At present, there is no official conclusion on the right and wrong of both doctors and patients.
On April 19, after the National Health Commission issued an investigation announcement on its official Weibo account @, it caused heated discussions among netizens.
After many days of public opinion fermentation, the reporter found that the most liked message on this Weibo was: "Check it out! Neither the doctor's heart nor the patient's heart can be chilled!"
On April 19, after the National Health Commission issued an investigation announcement on its official Weibo account @, it caused heated discussions among netizens.
After many days of public opinion fermentation, the reporter found that the most liked message on this Weibo was: "Check it out! Neither the doctor's heart nor the patient's heart can be chilled!"
Medical News, April 27.
Recently, clinician Zhang Yu published a long article on the Internet exposing the "shadow treatment of tumor", which caused a shock of public opinion.
On April 19, the National Health Commission responded on its official information platform that after it was concerned about the online information of "The third hospital of Beijing Medical College's oncologists reported the shady tumor treatment", it attached great importance to it and immediately organized the relevant situation and reported problems.
Investigate and verify.
Recently, clinician Zhang Yu published a long article on the Internet exposing the "shadow treatment of tumor", which caused a shock of public opinion.
On April 19, the National Health Commission responded on its official information platform that after it was concerned about the online information of "The third hospital of Beijing Medical College's oncologists reported the shady tumor treatment", it attached great importance to it and immediately organized the relevant situation and reported problems.
Investigate and verify.
Zhang Yu pointed out in a long article that a considerable proportion of cancer patients have spent unnecessary and expensive expenses, and a certain proportion of patients died due to irregular or even incorrect diagnosis and treatment.
Zhang Yu cited a tumor patient who had both financial and financial resources.
After receiving treatment by Lu Wei, deputy chief physician of Xinhua Hospital affiliated to Shanghai Jiaotong University, this patient died unfortunately and owed more than 100,000 yuan in debt.
Hospital hospital hospitalZhang Yu cited a tumor patient who had both financial and financial resources.
After receiving treatment by Lu Wei, deputy chief physician of Xinhua Hospital affiliated to Shanghai Jiaotong University, this patient died unfortunately and owed more than 100,000 yuan in debt.
Zhang Yu said that this patient "expensively increased by 10 times and died earlier" because of Lu Wei's treatment plan, which included abandoning the lower cost treatment plan and switching to the "extraordinary second-line treatment plan with sharply rising costs" and Ineffective, expensive, and illegal NK treatment.
Zhang Yu said that such a diagnosis and treatment plan is a typical over-medical behavior.
Zhang Yu said that such a diagnosis and treatment plan is a typical over-medical behavior.
China Youth Daily and China Youth Daily interviewed Zheng Xueqian, the executive vice chairman and secretary-general of the Medical Legal Professional Committee of the Chinese Hospital Association, an expert in petitions, medical administration, medical management, and legal consultation from the National Health Commission, and the director of Beijing Huawei Law Firm.
As an expert in the field of medical and health law, Zheng Xueqian has more than 30 years of experience in handling medical disputes.
She said that the Basic Medical and Health Promotion Law that came into effect in June 2020 clearly states that medical personnel should follow the laws of medical science and comply with relevant clinical practices.
Diagnosis and treatment technical specifications, various operating specifications, and medical ethics specifications, use appropriate technologies and drugs, make reasonable diagnosis and treatment, and treat patients due to diseases.
Excessive medical treatment shall not be performed on patients.
This is the first time that the country has written "excessive medical treatment" into the law.
The previous tort liability law used the term "excessive inspection".
She said that the Basic Medical and Health Promotion Law that came into effect in June 2020 clearly states that medical personnel should follow the laws of medical science and comply with relevant clinical practices.
Diagnosis and treatment technical specifications, various operating specifications, and medical ethics specifications, use appropriate technologies and drugs, make reasonable diagnosis and treatment, and treat patients due to diseases.
Excessive medical treatment shall not be performed on patients.
This is the first time that the country has written "excessive medical treatment" into the law.
The previous tort liability law used the term "excessive inspection".
Zheng Xueqian said: “Because excessive medical treatment is difficult to define.
Although many diseases in our country have standardized diagnosis and treatment guidelines, everyone’s situation is different.
When a patient has a special condition, the doctor cannot ignore it, so there may be some Adjust the plan.
" These tentative explorations that go beyond the diagnosis and treatment guidelines have become a fuzzy zone of whether it is over-medical.
Disease disease diseaseAlthough many diseases in our country have standardized diagnosis and treatment guidelines, everyone’s situation is different.
When a patient has a special condition, the doctor cannot ignore it, so there may be some Adjust the plan.
" These tentative explorations that go beyond the diagnosis and treatment guidelines have become a fuzzy zone of whether it is over-medical.
Zheng Xueqian believes that the important value of Zhang Yu's article exposing the "shadow of tumor treatment" is to make the country pay attention to this matter and standardize tumor treatment, while also reminding doctors of self-discipline.
In its response, the National Health Commission pointed out that once relevant issues are verified, they will be dealt with strictly according to laws and regulations, and will never be tolerated, and will continue to promote cancer diagnosis and treatment management, further improve the management system and standard system, strengthen supervision and guidance, and ensure relevant requirements Put it in place, focus on improving the standardization of tumor diagnosis and treatment, and safeguard the people's health rights.
Tumor tumor tumorIn its response, the National Health Commission pointed out that once relevant issues are verified, they will be dealt with strictly according to laws and regulations, and will never be tolerated, and will continue to promote cancer diagnosis and treatment management, further improve the management system and standard system, strengthen supervision and guidance, and ensure relevant requirements Put it in place, focus on improving the standardization of tumor diagnosis and treatment, and safeguard the people's health rights.
In an interview, Zheng Xueqian emphasized that although Dr.
Zhang Yu’s article has attracted a lot of attention, “but it does not mean that all tumor treatments are not standardized.
Over-medical treatment is only a rare phenomenon, and most doctors do not.
” Long-term handling of medical disputes.
Zheng Xueqian of China is worried that the slightly eased doctor-patient relationship in China's fight against the new crown pneumonia epidemic may be damaged by this incident.
Zhang Yu’s article has attracted a lot of attention, “but it does not mean that all tumor treatments are not standardized.
Over-medical treatment is only a rare phenomenon, and most doctors do not.
” Long-term handling of medical disputes.
Zheng Xueqian of China is worried that the slightly eased doctor-patient relationship in China's fight against the new crown pneumonia epidemic may be damaged by this incident.
Zheng Xueqian said that excessive medical treatment is more of an ethical issue.
She told reporters that she had participated in a medical ethics committee meeting of a hospital.
It is also a patient with advanced cancer.
The domestic known treatment options have been used, but they are still ineffective.
The patient learned that a foreign pharmaceutical company was conducting a clinical trial of a new drug.
It was said that the effect was good, but the drug was not yet on the market.
The patient wants to buy this unlisted drug for treatment, but the pharmaceutical company needs him to prescribe it in China.
She told reporters that she had participated in a medical ethics committee meeting of a hospital.
It is also a patient with advanced cancer.
The domestic known treatment options have been used, but they are still ineffective.
The patient learned that a foreign pharmaceutical company was conducting a clinical trial of a new drug.
It was said that the effect was good, but the drug was not yet on the market.
The patient wants to buy this unlisted drug for treatment, but the pharmaceutical company needs him to prescribe it in China.
This case not only provides a solution to avoid excessive medical treatment.
At the same time, it also illustrates the complexity and uncertainty of tumor treatment, especially in the treatment of advanced malignant tumors, the problem will be more prominent.
How to strike a balance between exploratory treatment and normative guidelines? Zheng Xueqian believes that the supervision of policies pharmnet.
com.
cn/" target="_blank">and regulations , including the National Health Commission and the National Medical Insurance Bureau, must be necessary; in addition, hospitals should also do related self-examination work, which includes ethical review of the new technology diagnosis and treatment process, which is complicated Tumor medication plans should carry out multidisciplinary consultations or review by superior doctors in the department; finally, doctors should do a good job of personal self-discipline, not only to practice according to law, but also to consider the patient's experience in the diagnosis and treatment process.
pharmnet. At the same time, it also illustrates the complexity and uncertainty of tumor treatment, especially in the treatment of advanced malignant tumors, the problem will be more prominent.
How to strike a balance between exploratory treatment and normative guidelines? Zheng Xueqian believes that the supervision of policies pharmnet.
com.
cn/" target="_blank">and regulations , including the National Health Commission and the National Medical Insurance Bureau, must be necessary; in addition, hospitals should also do related self-examination work, which includes ethical review of the new technology diagnosis and treatment process, which is complicated Tumor medication plans should carry out multidisciplinary consultations or review by superior doctors in the department; finally, doctors should do a good job of personal self-discipline, not only to practice according to law, but also to consider the patient's experience in the diagnosis and treatment process.
com.
cn/" target="_blank">Regulationspharmnet.
com.
cn/" target="_blank"> and regulations
The implementation of the above-mentioned various supervisory measures must ultimately be based on the fact that doctors should objectively clarify the pros and cons for patients, and seek patient consent, rather than actively induce them.
One of the core controversies of the "tumor treatment shady" revealed by Dr.
Zhang Yu this time is whether the NK therapy worth tens of thousands of dollars was requested by the patient or induced by the doctor.
According to related reports, the daughter of the deceased patient insisted that this treatment plan was recommended by Lu Wei, while Lu Wei said in an interview with the media that it was not his introduction, but that the family members learned about it from other channels and came to consult.
Lu Wei said After finishing the principle, the family decided to use NK therapy.
Zhang Yu this time is whether the NK therapy worth tens of thousands of dollars was requested by the patient or induced by the doctor.
According to related reports, the daughter of the deceased patient insisted that this treatment plan was recommended by Lu Wei, while Lu Wei said in an interview with the media that it was not his introduction, but that the family members learned about it from other channels and came to consult.
Lu Wei said After finishing the principle, the family decided to use NK therapy.
At present, there is no official conclusion on the right and wrong of both doctors and patients.
On April 19, after the National Health Commission issued an investigation announcement on its official Weibo account @, it caused heated discussions among netizens.
After many days of public opinion fermentation, the reporter found that the most liked message on this Weibo was: "Check it out! Neither the doctor's heart nor the patient's heart can be chilled!"
Healthy, healthy, healthy On April 19, after the National Health Commission issued an investigation announcement on its official Weibo account @, it caused heated discussions among netizens.
After many days of public opinion fermentation, the reporter found that the most liked message on this Weibo was: "Check it out! Neither the doctor's heart nor the patient's heart can be chilled!"
